Johnson & Johnson

DJNJ3.BA·Buenos Aires·Healthcare
Compare
1,781.000.00 (0.00%)today
At close: Nov 19, 4:55 PM ART · May be delayed up to 20 min · ARS

Prices may be delayed up to 20 min. Not investment advice. News volume: articles about it in the 4Search index. Click a dot on the chart for the event and the news of that day.

Key statistics

Previous close1,781.00
Open1,781.00
Day range—
52-week range1,640.001,781.00
Off day high0.00%
Off 52-week high0.00%
Volume13.00
Avg. volume (3M)0.00
Market cap4.29T
EPS (TTM)12,067.88
Forward P/E—
P/E ratio (TTM)0.15
Dividend yield2.93% (48.08)
Beta (5Y)0.20
Shares outstanding2.41B
Short interest—
Earnings date—
Analyst target—
Profit margin16.20%

Against its peers

Compare in full ›
DJNJ3.BA JNJ.NE LLY.NE MRK AZN.L 4552.T
Market cap 4.29T 895.29B 1.65T 329.65B 208.01B 58.57B
P/E (TTM) 0.1 24.8 62.3 135.1 25.2 —
Forward P/E — — — 14.9 15.8 13.1
Price/book 0.5 0.8 1.3 7.3 5.4 1.4
Dividend yield 2.93% 2.49% 0.58% 2.63% 1.78% 4.05%
1-year change −5.86% +40.84% +35.37% +33.19% −3.75% −22.20%
Today 0.00% +1.95% −0.23% +0.69% +0.81% −2.83%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.

Latest news

All DJNJ3.BA news ›
MarketScreener··2 outletsNegative

Johnson & Johnson Seeks Expanded FDA Approval for Caplyta in Bipolar Mania

Published on 11/19/2026 at 08:53 am EST - Modified on 11/19/2026 at 08:54 am EST Johnson & Johnson has filed for expanded U.S. Food and Drug Administration approval for its Caplyta antipsychotic medication in bipolar mania. J&J said the…

JNJ
More from 1 other outlet

From the 4Search news index, newest first.

In the news

107mentions in 30 days
107with it in the headline
Mixedsentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 107 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use. How to use Finance